MINI REVIEW
Accepted on 30 Apr 2026
Antibody Targeting of the TNF–TNFR2 Axis to Overcome Tumor Immune Resistance
- 199 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- AntibodyPlus Therapeutics in Oncology: Innovative Mechanisms, Therapeutic Strategies, and Clinical Advances
AntibodyPlus Therapeutics in Oncology: Innovative Mechanisms, Therapeutic Strategies, and Clinical Advances
2,141
Total downloads
18k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 15 Apr 2026
A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death
doi 10.3389/fonc.2026.1748576
- 446 views
MINI REVIEW
Published on 07 Apr 2026
Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation
doi 10.3389/fimmu.2026.1805770
- 458 views
REVIEW
Published on 18 Feb 2026
Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer
doi 10.3389/fimmu.2026.1787148
- 1,143 views
- 1 citation
REVIEW
Published on 11 Feb 2026
Clinical trials of bispecific antibody therapy for colorectal cancer: advanced and next steps
doi 10.3389/fonc.2026.1758251
- 1,567 views
ORIGINAL RESEARCH
Published on 11 Feb 2026
A fully human IgG1 antibody targeting MICA α1 domain inhibits interaction with NKG2D and activates immune effector functions against MICA-expressing cells
doi 10.3389/fimmu.2026.1740184
- 1,135 views
MINI REVIEW
Published on 05 Feb 2026
Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
doi 10.3389/or.2026.1781533
- 1,688 views
- 1 citation
ORIGINAL RESEARCH
Published on 23 Jan 2026
Development and characterization of a novel B7-H3 rabbit monoclonal antibody for glioma diagnosis
doi 10.3389/fphar.2026.1736583
- 1,058 views
ORIGINAL RESEARCH
Published on 07 Nov 2025
Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacy
doi 10.3389/fimmu.2025.1711433
- 2,288 views
MINI REVIEW
Published on 05 Nov 2025
Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges
doi 10.3389/fimmu.2025.1712344
- 2,654 views
ORIGINAL RESEARCH
Published on 27 Oct 2025
Biparatopic HER2-targeted nanobody binder synergizes with trastuzumab in resistant tumor cells
doi 10.3389/fimmu.2025.1711448
- 2,447 views
- 1 citation
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore